Search - tctmd.com

Displaying 141 - 160 of 519

Sort: Relevancy | Date

Presentation TCT 2015

The Clinical Impact of Stroke With 2 Preventative Strategies: LAA Closure vs Chronic Oral Anticoagulation

Presenter: Reda Ibrahim, Matthew J. Price, Vivek Y. Reddy

October 11, 2015

Presentation TCT 2015

Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? Yes, LAA Closure Is at Least as Good as Oral Anticoagulation!

Presenter: Reda Ibrahim, Matthew J. Price, Saibal Kar

October 11, 2015

Presentation TCT 2015

Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? No, It Should Be Limited to Anticoagulation Contraindicated Patients!

Presenter: Reda Ibrahim, Matthew J. Price, Jai-Wun Park

October 11, 2015

Presentation TCT 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano

October 11, 2015

Presentation TCT 2015

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Neal S. Kleiman

October 11, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

News Conference News TCT 2015

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Nicole Lou

October 11, 2015

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

News Daily News

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

L.A. McKeown

October 08, 2015

News Industry News

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

September 25, 2015

News Daily News

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

L.A. McKeown

September 21, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Daily News

Bivalirudina Upstream en Pacientes SCASEST resulta Óptima Con Estrategia Invasiva Programada

L.A. McKeown

September 21, 2015

Presentation

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Presenter: Tobias Geisler

September 18, 2015

News Industry News

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

September 16, 2015

News Daily News

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

Todd Neale

September 10, 2015

News Conference News ESC 2015

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Yael L. Maxwell

August 31, 2015

News Conference News ESC 2015

Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients

L.A. McKeown

August 31, 2015

News Industry News

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

August 24, 2015

Advertisement

The Clinical Impact of Stroke With 2 Preventative Strategies: LAA Closure vs Chronic Oral Anticoagulation

Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? Yes, LAA Closure Is at Least as Good as Oral Anticoagulation!

Debate: Is LAA Closure an Alternative to Oral Anticoagulation in Low Bleeding Risk Patients? No, It Should Be Limited to Anticoagulation Contraindicated Patients!

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Weighing the Risk of Stroke in Atrial Fibrillation vs the Risk of Bleeding on Anticoagulation

Use of LAA Occlusion in Low-Risk Patients Debated

Cath Lab Economics: Pursuit of a Light at the End of the Tunnel

Scripps experts present at 2015 TCT scientific symposium

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

CHMP grants positive opinion for idarucizumab, the specific reversal agent for dabigatran etexilate (Pradaxa®)

在已有侵入性策略安排的NSTE-ACS患者中，上游比伐卢定的效果最好

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

Bivalirudina Upstream en Pacientes SCASEST resulta Óptima Con Estrategia Invasiva Programada

Impact of Anticoagulation Regimen Prior toRevascularization in Patients With NSTE-ACS

Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints

Patients With Acute Pulmonary Embolism Fare Better With More-Targeted Thrombolysis

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients

Acute Pulmonary Embolism Trial (SEATTLE II) Published in the JACC: Cardiovascular Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content